As of 2026-04-04, the Relative Valuation of Aurisco Pharmaceutical Co Ltd (605116.SS) is 28.14 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 30.60 CNY, the upside of Aurisco Pharmaceutical Co Ltd based on Relative Valuation is -8.0%.
The range of the Relative Valuation is 23.42 - 33.81 CNY.
| Range | Selected | |
| Trailing P/E multiples | 23.7x - 30.8x | 28.8x |
| Forward P/E multiples | 20.3x - 28.6x | 23.5x |
| Fair Price | 23.42 - 33.81 | 28.14 |
| Upside | -23.5% - 10.5% | -8.0% |
| Date | P/E |
| 2026-03-27 | 27.02 |
| 2026-03-26 | 25.34 |
| 2026-03-25 | 25.37 |
| 2026-03-24 | 25.32 |
| 2026-03-23 | 24.69 |
| 2026-03-20 | 26.27 |
| 2026-03-19 | 26.28 |
| 2026-03-18 | 26.68 |
| 2026-03-17 | 27.14 |
| 2026-03-16 | 26.85 |
| 2026-03-13 | 26.03 |
| 2026-03-12 | 25.95 |
| 2026-03-11 | 26.13 |
| 2026-03-10 | 26.45 |
| 2026-03-09 | 26.08 |
| 2026-03-06 | 25.84 |
| 2026-03-05 | 25.27 |
| 2026-03-04 | 24.97 |
| 2026-03-03 | 25.32 |
| 2026-03-02 | 25.85 |
| 2026-02-27 | 26.88 |
| 2026-02-26 | 26.86 |
| 2026-02-25 | 26.93 |
| 2026-02-24 | 27.01 |
| 2026-02-13 | 26.87 |
| 2026-02-12 | 27.27 |
| 2026-02-11 | 27.29 |
| 2026-02-10 | 27.37 |
| 2026-02-09 | 27.46 |
| 2026-02-06 | 27.96 |
| 2026-02-05 | 27.77 |
| 2026-02-04 | 27.77 |
| 2026-02-03 | 27.64 |
| 2026-02-02 | 27.00 |
| 2026-01-30 | 29.05 |
| 2026-01-29 | 29.08 |
| 2026-01-28 | 29.56 |
| 2026-01-27 | 30.73 |
| 2026-01-26 | 31.05 |
| 2026-01-23 | 31.69 |
| 2026-01-22 | 31.38 |
| 2026-01-21 | 31.54 |
| 2026-01-20 | 31.95 |
| 2026-01-19 | 32.76 |
| 2026-01-16 | 34.87 |
| 2026-01-15 | 32.88 |
| 2026-01-14 | 32.30 |
| 2026-01-13 | 31.93 |
| 2026-01-12 | 31.19 |
| 2026-01-09 | 31.08 |